MD l Endocrinology/Internal Medicine l Diabetes & Chronic NCDs Healthcare & Research at Public Healthcare Services in Mexico🇲🇽
Ciudad de México
Joined January 2012
- Tweets652
- Following838
- Followers968
- Likes4.6K
Pinned Tweet
We recently reported diabetes care target attainment in 316,947 adults receiving care in Mexico’s federalized public health system.
Against WHO Global Diabetes Compact 2030 minimum targets:
🎯 HbA1c <8%: 59.3%
🎯 BP <140/90 mmHg: 76.6%
🎯 Statin use ≥40 y: 30.2%
👇
We recently reported how routine clinical data can support hypertension care monitoring at scale in Mexico.
Among 322,661 adults in active follow-up:
• 67.2% had BP <140/90 mmHg
• 36.8% had BP <130/80 mmHg
👇
📄 doi.org/10.1177/117863292614…
Among patients with suboptimal BP control:
• 63.8% had follow-up within 4 weeks
• 48.1% had treatment intensification
Continuous monitoring can identify care gaps and guide targeted improvement.
Evidence into better health decisions.
#Hypertension #PrimaryCare #HealthSystems
Continuous performance monitoring can identify where improvement is most needed and help guide targeted action in primary care.
📄 doi.org/10.3389/fcdhc.2026.1…
Evidence into better health decisions.
#Diabetes #PrimaryCare #HealthSystems
More than 1 in 2 adults with type 2 diabetes had MASLD in our primary care cohort in Mexico.
And 22.7% had intermediate-to-high fibrosis risk.
Liver disease is already a major part of diabetes care.
🤖 Made with AI
A key finding: 57% of adults with MASLD and 43.6% of those with increased fibrosis risk had normal liver enzymes.
ALT/AST alone may miss many patients.
📄 doi.org/10.1016/j.clinme.202…
Evidence into better health decisions.
#MASLD #Diabetes #PrimaryCare
Recently, we examined diabetes-related complications in adults with type 2 diabetes receiving primary care in Mexico.
70.5% already had at least one diabetes-related complication.
Are we identifying complications early enough?
👇
Complications were associated with a progressive decline in health-related quality of life, reinforcing the importance of prevention, systematic screening, and timely intervention in primary care.
📄 doi.org/10.3389/fcdhc.2026.1…
Evidence into better health decisions.
#Diabetes
Contento de compartir nuestra nueva publicación👇
"Cumulative burden of diabetes-related complications and health-related quality of life in primary care: a cross sectional study from Mexico"
frontiersin.org/journals/cli…
Exploramos la presencia de complicaciones por diabetes y su asociación con los diferentes aspectos relacionados a la calidad de vida en personas atendidas en el primer nivel de atención en #México 🇲🇽.
En la atención de enfermedades crónicas el objetivo principal, después de todo, es preservar y optimizar la #calidaddevida.
Planteamos la relevancia de un enfoque centrado en la calidad de vida y el fortalecimiento del primer nivel de atención para mitigar la carga por #diabetes
We are pleased to share the preliminary results of a care strategy for diabetes prevention among individuals with prediabetes, implemented within Mexico's public health system. 🇲🇽
👇
doi.org/10.1016/j.clinme.202…
#diabetes #prediabetes #Mexico
Con satisfacción comparto los resultados preliminares de una estrategia de atención para la prevención de diabetes en personas con prediabetes, implementada en el sistema de salud pública de México🇲🇽
👇
doi.org/10.1016/j.clinme.202…
#diabetes #prediabetes #Mexico
Proud to share our recent findings on sarcopenia and morphofunctional changes in people with type 2 diabetes in Mexico at IDF Congress 2025; and returning with plenty of new ideas to improve diabetes care in our country #IDF2025 @IntDiabetesFed
Tuve la oportunidad de participar en la elaboración del Protocolo Nacional de Atención Médica para Diabetes tipo 2.
👇
pronamsalud.csg.gob.mx
pronamsalud.csg.gob.mx/infog…
En la medida que logremos incorporar estas intervenciones basadas en evidencia en la atención de nuestros pacientes, estaremos incidiendo en la calidad de vida y pronóstico de una de las condiciones de mayor impacto en nuestra población.
Además incluimos el Manual para Personas que Viven con Diabetes desarrollado en la Clínica de Diabetes Ciudad de México de nuestro IMSS-Bienestar. Les invito a conocer estos documentos.
pronamsalud.csg.gob.mx/manua…
I’ll be presenting at the IDF Congress on April 9 in Bangkok! #IDF2025 @IntDiabetesFed #diabetes #sarcopenia #primarycare #Mexico
Investigamos la prevalencia de alteraciones morfofuncionales, incluyendo sarcopenia, en personas con diabetes en el primer nivel de atención. 👇🏼
sciencedirect.com/science/ar…
We investigated the prevalence of altered morphofunctional phenotypes, including sarcopenia, in primary care settings.
@caml1225
Prevalence of diabetes-related sarcopenia... sciencedirect.com/science/ar…
@kamleshkhunti @felipeisidro13 @DrMijailTapia @DiegoBellido2
